Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Our report is an authoritative Owner’s Manual on the company.
- A vital piece in the investor’s toolbox, our report allows you to uncover the essence of the business
- We pinpoint strengths and weaknesses; discuss strategy
- Our aim is to make deep knowledge about the company readily available, saving investors time and enabling dialogue

We offer our research as a service for Japanese corporates.
- Our in-depth reports allow them to better inform investors by presenting an unbiased third-party view of business fundamentals
- Our reports do not offer investment opinions and are free for all investors

We start our coverage with a substantial core report.
- We continuously update this report to reflect earnings, news flow, and any material developments
- We thoroughly interview management on a quarterly basis

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

Sakai Chemical Industry Co / Equity Bottom-Up

<ul><li>FY03/25 revenue reached JPY84.4bn, a 2.8% YoY increase; operating profit rose 107.1% YoY to JPY6.1bn.</li><li>Electronic materials revenue grew 27.5% YoY; titanium dioxide and zinc products turned profitable, aiding overall recovery.</li><li>FY03/26 outlook projects revenue of JPY86.0bn (+1.9% YoY) and operating profit of JPY6.5bn (+6.7% YoY).</li></ul>

FY03/25 revenue reached JPY84.4bn, a 2.8% YoY increase; operating profit rose 107.1% YoY to JPY6.1bn.Electronic materials revenue grew 27.5% YoY; titanium dioxide and zinc products turned profitable, aiding overall recovery.FY03/26 outlook projects revenue of JPY86.0bn (+1.9% YoY) and operating profit of JPY6.5bn (+6.7% YoY).

Sakai Chemical Industry Co (4078 JP): Full-year FY03/25 flash update